415 related articles for article (PubMed ID: 21140010)
1. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
Heeres JT; Hergenrother PJ
Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
[TBL] [Abstract][Full Text] [Related]
2. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
3. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
4. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
5. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
6. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput, homogeneous, fluorescence resonance energy transfer-based assay for phospho-N-acetylmuramoyl-pentapeptide translocase (MraY).
Shapiro AB; Jahić H; Gao N; Hajec L; Rivin O
J Biomol Screen; 2012 Jun; 17(5):662-72. PubMed ID: 22337656
[TBL] [Abstract][Full Text] [Related]
8. MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCV.
Van Schoubroeck B; Van Acker K; Dams G; Jochmans D; Clayton R; Berke JM; Lievens S; Van der Heyden J; Tavernier J
Methods Mol Biol; 2012; 812():295-307. PubMed ID: 22218868
[TBL] [Abstract][Full Text] [Related]
9. Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process.
Danielson UH
Future Med Chem; 2009 Nov; 1(8):1399-414. PubMed ID: 21426056
[TBL] [Abstract][Full Text] [Related]
10. A universal homogeneous assay for high-throughput determination of binding kinetics.
Schiele F; Ayaz P; Fernández-Montalván A
Anal Biochem; 2015 Jan; 468():42-9. PubMed ID: 25240173
[TBL] [Abstract][Full Text] [Related]
11. Functional assays for screening GPCR targets.
Thomsen W; Frazer J; Unett D
Curr Opin Biotechnol; 2005 Dec; 16(6):655-65. PubMed ID: 16257523
[TBL] [Abstract][Full Text] [Related]
12. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput fluorescence resonance energy transfer (FRET)-based endothelial cell apoptosis assay and its application for screening vascular disrupting agents.
Zhu X; Fu A; Luo KQ
Biochem Biophys Res Commun; 2012 Feb; 418(4):641-6. PubMed ID: 22290227
[TBL] [Abstract][Full Text] [Related]
14. Assessing GPCR activation using protein complementation: a novel technique for HTS.
Eglen RM
Biochem Soc Trans; 2007 Aug; 35(Pt 4):746-8. PubMed ID: 17635139
[TBL] [Abstract][Full Text] [Related]
15. Thermally denatured BSA, a surrogate additive to replace BSA in buffers for high-throughput screening.
Peña I; Domínguez JM
J Biomol Screen; 2010 Dec; 15(10):1281-6. PubMed ID: 20847192
[TBL] [Abstract][Full Text] [Related]
16. Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors.
McWhirter C; Tonge M; Plant H; Hardern I; Nissink W; Durant ST
J Biomol Screen; 2013 Jun; 18(5):567-75. PubMed ID: 23427045
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.
Prével C; Kurzawa L; Van TN; Morris MC
Eur J Med Chem; 2014 Dec; 88():74-88. PubMed ID: 25314935
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent biosensors for high throughput screening of protein kinase inhibitors.
Prével C; Pellerano M; Van TN; Morris MC
Biotechnol J; 2014 Feb; 9(2):253-65. PubMed ID: 24357625
[TBL] [Abstract][Full Text] [Related]
19. Cell-impedance-based label-free technology for the identification of new drugs.
Lundstrom K
Expert Opin Drug Discov; 2017 Apr; 12(4):335-343. PubMed ID: 28276704
[TBL] [Abstract][Full Text] [Related]
20. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
Drewry DH; Macarron R
Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
